HOLX (Hologic) Ending Cash Position: $2,168 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HOLX Hologic Inc HOLX
57 GF Score
Price $76.01
GF Value $82.05
! 5 Warning Signs
View Full Analysis

What is Hologic Ending Cash Position?

Hologic HOLX 57 Ending Cash Position is $2,168 Mil as of Dec. 2025. GuruFocus rates HOLX with a GF Score™ of 57/100 and a GF Value™ of $82.05. The stock has 5 warning signs investors should review.

Hologic's Ending Cash Position for the quarter that ended in Dec. 2025 was $2,168 Mil.

Hologic's quarterly Ending Cash Position increased from Jun. 2025 ($1,735 Mil) to Sep. 2025 ($1,960 Mil) and increased from Sep. 2025 ($1,960 Mil) to Dec. 2025 ($2,168 Mil).

Hologic's annual Ending Cash Position declined from Sep. 2023 ($2,756 Mil) to Sep. 2024 ($2,160 Mil) and declined from Sep. 2024 ($2,160 Mil) to Sep. 2025 ($1,960 Mil).

Hologic Ending Cash Position Related Terms

Hologic Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Hologic's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hologic Ending Cash Position Chart

Hologic Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,170.30 2,339.50 2,755.70 2,160.20 1,959.50

Hologic Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,782.10 1,429.50 1,735.20 1,959.50 2,168.00
HOLX
57GF Score
Hologic Inc HOLX
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hologic Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hologic's Ending Cash Position for the fiscal year that ended in Sep. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=2160.2+-200.7
=1,960

Hologic's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1959.5+208.5
=2,168

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $2,168 Mil mean?
Hologic (HOLX) has a Ending Cash Position of $2,168 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Hologic and its competitors.
Is Hologic's Ending Cash Position too high?
Hologic's current Ending Cash Position is $2,168 Mil. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's Ending Cash Position compare to WST and COO?
Hologic's Ending Cash Position of $2,168 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Hologic and its competitors. Hologic's current Ending Cash Position is $2,168 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (HOLX) has a current Ending Cash Position of $2,168 Mil. The stock's GF Value™ is $82.05, compared to a current price of $76.01 — trading 7.4% below its estimated fair value. The current Ending Cash Position is $2,168 Mil. Hologic's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Hologic (HOLX), the current Ending Cash Position is $2,168 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hologic (HOLX) Overvalued in 2026?

Based on GuruFocus' analysis, Hologic stock appears to be undervalued. The current stock price of $76.01 is trading 7.4% below its estimated GF Value™ of $82.05.

Key valuation signals for HOLX:

  • Ending Cash Position: $2,168 Mil
  • GF Value™: $82.05 vs. price of $76.01 (7.4% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the HOLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hologic Business Description

Address 250 Campus Drive, Marlborough, MA, USA, 01752
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score

Get the complete analysis for HOLX

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$76.01
Price
$82.05
GF Value